UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes

Nature communications, 2021-09, Vol.12 (1), p.5503-8, Article 5503

2021

Volltextzugriff (PDF)

Telaprevir for Previously Treated Chronic HCV Infection

The New England journal of medicine, 2010-04, Vol.362 (14), p.1292-1303

2010

Volltextzugriff (PDF)

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma

PloS one, 2010-08, Vol.5 (8), p.e12419-e12419

2010

Volltextzugriff (PDF)

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

The American journal of gastroenterology, 1999-09, Vol.94 (9), p.2467-2474

1999

Volltextzugriff (PDF)

Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells

Journal of virology, 2017-03, Vol.91 (6)

2017

Volltextzugriff (PDF)

Analysis of GNSS-R delay-Doppler maps from the UK-DMC satellite over the ocean

Geophysical research letters, 2009-01, Vol.36 (2), p.L02608-n/a

2009

Volltextzugriff (PDF)

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

Journal of hepatology, 2020-09, Vol.73 (3), p.540-548

2020

Volltextzugriff (PDF)

Hepatitis C Virus Induces Epithelial-Mesenchymal Transition in Primary Human Hepatocytes

Journal of Virology, 2012-12, Vol.86 (24), p.13621-13628

2012

Volltextzugriff (PDF)

Editorial: Feeling better about NASH

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (4), p.482-483

Di Bisceglie, Adrian M

2023

Volltextzugriff (PDF)

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

JNCI : Journal of the National Cancer Institute, 2008-05, Vol.100 (10), p.698-711

2008

Volltextzugriff (PDF)

Identification and Development of Fucosylated Glycoproteins as Biomarkers of Primary Hepatocellular Carcinoma

Journal of proteome research, 2009-02, Vol.8 (2), p.595-602

2009

Volltextzugriff (PDF)

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

The New England journal of medicine, 2014-05, Vol.370 (20), p.1879-1888

2014

Volltextzugriff (PDF)

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

The New England journal of medicine, 2011-06, Vol.364 (25), p.2405-2416

2011

Volltextzugriff (PDF)

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

The New England journal of medicine, 2014-04, Vol.370 (17), p.1604-1614

2014

Volltextzugriff (PDF)

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

The New England journal of medicine, 2014-04, Vol.370 (16), p.1483-1493

2014

Volltextzugriff (PDF)

CFAR detection of extended objects in high-resolution SAR images

IEEE transactions on geoscience and remote sensing, 2005-04, Vol.43 (4), p.833-843

2005

Volltextzugriff (PDF)

Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research network

Liver transplantation, 2016-01, Vol.22 (1), p.24-33

2016

Volltextzugriff (PDF)

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5‐year follow‐up of 150 patients

Hepatology (Baltimore, Md.), 2009-03, Vol.49 (3), p.729-738

2009

Volltextzugriff (PDF)

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

Hepatology (Baltimore, Md.), 2008-04, Vol.47 (4), p.1363-1370

2008

Volltextzugriff (PDF)

Natural history of hepatitis C: Its impact on clinical management

Hepatology (Baltimore, Md.), 2000-04, Vol.31 (4), p.1014-1018

Di Bisceglie, Adrian M.

2000

Volltextzugriff (PDF)

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

Gastroenterology (New York, N.Y. 1943), 2009-01, Vol.136 (1), p.138-148

2009

Volltextzugriff (PDF)

Hepatitis C

The Lancet (British edition), 1998-01, Vol.351 (9099), p.351-355

Di Bisceglie, Adrian M

1998

Volltextzugriff (PDF)

Within-host quantitation of anellovirus genome complexity from clinical samples

Journal of virological methods, 2022-04, Vol.302, p.114493-114493, Article 114493

2022

Volltextzugriff (PDF)

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

Gastroenterology (New York, N.Y. 1943), 2016-12, Vol.151 (6), p.1131-1140.e5

2016

Volltextzugriff (PDF)

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial

The American journal of gastroenterology, 2023-07, Vol.118 (7), p.1226-1236

2023

Volltextzugriff (PDF)

1 – 25 von 683

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(658)
Mit Volltextzugriff
(547)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(4)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes

Telaprevir for Previously Treated Chronic HCV Infection

Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells

Analysis of GNSS-R delay-Doppler maps from the UK-DMC satellite over the ocean

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

Hepatitis C Virus Induces Epithelial-Mesenchymal Transition in Primary Human Hepatocytes

Editorial: Feeling better about NASH

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

Identification and Development of Fucosylated Glycoproteins as Biomarkers of Primary Hepatocellular Carcinoma

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

CFAR detection of extended objects in high-resolution SAR images

Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research network

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5‐year follow‐up of 150 patients

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

Natural history of hepatitis C: Its impact on clinical management

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

Hepatitis C

Within-host quantitation of anellovirus genome complexity from clinical samples

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial

Aktive Filter

Suchergebnisse filtern